🇺🇸 Fluticasone Propionate (FP) in United States
11 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 11
Most-reported reactions
- Drug Interaction — 2 reports (18.18%)
- Abdominal Pain Upper — 1 report (9.09%)
- Contusion — 1 report (9.09%)
- Cushing^S Syndrome — 1 report (9.09%)
- Decreased Appetite — 1 report (9.09%)
- Diarrhoea — 1 report (9.09%)
- Hirsutism — 1 report (9.09%)
- Livedo Reticularis — 1 report (9.09%)
- Malaise — 1 report (9.09%)
- Nausea — 1 report (9.09%)
Other Respiratory / Pulmonology approved in United States
Frequently asked questions
Is Fluticasone Propionate (FP) approved in United States?
Fluticasone Propionate (FP) does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Fluticasone Propionate (FP) in United States?
Dey is the originator. The local marketing authorisation holder may differ — check the official source linked above.